Abstract
This review discusses the standard and accepted method of [human] bladder cancer screening as well as cytologic examination of urine and presents more recent investigations directed toward early bladder cancer detection and evaluation of its biologic potential. Reviewed areas include urine cytology in bladder cancer screening, cytogenetic evaluation of bladder tumors, biologic markers in bladder cancer and immunologic aspects of bladder cancer evaluation.